LEANDREA SQUIRES: Open Payments
NPI 1730609942 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 58 payments from 15 companies in 2025. Trend: 2023 $2,094 · 2024 $67 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $353 |
| Corcept Therapeutics | 6 | $121 |
| Novo Nordisk Inc | 4 | $79 |
| Lilly USA, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: UBRELVY, Korlym, VRAYLAR, QULIPTA, CREON, MOUNJARO, TRELEGY ELLIPTA, Wegovy.
Industry payments across OH — which companies pay providers there.
